| 臺大學術典藏 |
2020-05-26T09:26:40Z |
EGFR mutation detection in circulating cell-free DNA of lung adenocarcinoma patients: Analysis of LUX-Lung 3 and 6
|
Chih-Hsin Yang;Kim M;Massey D;Gibson N;Hirsh V;O'Byrne K;Yamamoto N;Mok T;Schuler M;Hou M;Li W;Huang Y;Lu S;Feng J;Hu C.-P;Sequist L.V;Wu Y.-L; Wu Y.-L; Sequist L.V; Hu C.-P; Feng J; Lu S; Huang Y; Li W; Hou M; Schuler M; Mok T; Yamamoto N; O'Byrne K; Hirsh V; Gibson N; Massey D; Kim M; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:37Z |
Scientific Advances in Thoracic Oncology 2016
|
Spigel D.R.;Hirsch F.R;Gandara D.R;Scagliotti G.V;Leighl N.B;Kelly R.J;Baas P;Tsao A;Rudin C.M;Faivre-Finn C;Wynes M.W;Peters S;Gettinger S;Horn L;Patel J.D;Costa D.B;Ahn M.-J;Shaw A.T;Sequist L.V;Chih-Hsin Yang;Johnson M;Kim D.-W;Solomon B;Senan S;Higgins K;Wu Y.-L;Wakelee H.A;Donington J;Asamura H;Lim E;Detterbeck F.C;Rami-Porta R;Dacic S;Bubendorf L;Yatabe Y;Mulshine J.L;Groen H.J.M;Field J.K;Jett J.R;Cummings K.M;Stone E.C.A;Soo R.A; Soo R.A; Stone E.C.A; Cummings K.M; Jett J.R; Field J.K; Groen H.J.M; Mulshine J.L; Yatabe Y; Bubendorf L; Dacic S; Rami-Porta R; Detterbeck F.C; Lim E; Asamura H; Donington J; Wakelee H.A; Wu Y.-L; Higgins K; Senan S; Solomon B; Kim D.-W; Johnson M; CHIH-HSIN YANG; Sequist L.V; Shaw A.T; Ahn M.-J; Costa D.B; Patel J.D; Horn L; Gettinger S; Peters S; Wynes M.W; Faivre-Finn C; Rudin C.M; Tsao A; Baas P; Kelly R.J; Leighl N.B; Scagliotti G.V; Gandara D.R; Hirsch F.R; Spigel D.R. |
| 臺大學術典藏 |
2020-05-26T09:26:34Z |
Phase II study of crizotinib in east asian patients with ROS1-positive advanced non?�small-cell lung cancer
|
Goto K.;Wilner K.D;Usari T;Paolini J;Roychowdhury D;Kemner A;Yamanaka T;Takahashi T;Ahn M.-J;Yamamoto N;Yang J.-J;Seto T;Zhou J;Lu S;Kim D.-W;Chih-Hsin Yang;Wu Y.-L; Wu Y.-L; CHIH-HSIN YANG; Kim D.-W; Lu S; Zhou J; Seto T; Yang J.-J; Yamamoto N; Ahn M.-J; Takahashi T; Yamanaka T; Kemner A; Roychowdhury D; Paolini J; Usari T; Wilner K.D; Goto K. |
| 臺大學術典藏 |
2020-05-26T09:26:34Z |
Gefitinib plus chemotherapy versus chemotherapy in epidermal growth factor receptor mutation-positive non-small-cell lung cancer resistant to first-line gefitinib (IMPRESS): Overall survival and biomarker analyses
|
Soria J.-C.;Thress K.S;Haddad V;Rukazenkov Y;Shi X;Ponce S;Atagi S;Lu Y;Chih-Hsin Yang;Wang J;Ahn M.-J;Yang J.-J;Nakagawa K;Wu Y.-L;Kim S.-W;Mok T.S.K; Mok T.S.K; Kim S.-W; Wu Y.-L; Nakagawa K; Yang J.-J; Ahn M.-J; Wang J; CHIH-HSIN YANG; Lu Y; Atagi S; Ponce S; Shi X; Rukazenkov Y; Haddad V; Thress K.S; Soria J.-C. |
| 臺大學術典藏 |
2020-05-26T09:26:32Z |
Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6)
|
O?�Byrne K; Geater S.L; Zhou C; Massey D; Märten A; Lungershausen J; CHIH-HSIN YANG; Schuler M; Mok T; Yamamoto N; Huang Y; Lu S; Hu C.-P; Feng J; Sequist L.V; Hirsh V; Wu Y.-L; Chih-Hsin Yang;Lungershausen J;M?rten A;Massey D;Zhou C;Geater S.L;O??Byrne K;Yamamoto N;Mok T;Schuler M;Huang Y;Lu S;Feng J;Hu C.-P;Sequist L.V;Hirsh V;Wu Y.-L |
| 臺大學術典藏 |
2020-05-26T09:26:28Z |
The Value of Early Depth of Response in Predicting Long-Term Outcome in EGFR-Mutant Lung Cancer
|
Chih-Hsin Chih-Hsin Yang;Mok T;Gralla R;Gebski V;Davies L;Asher R;Mitsudomi T;Fukuoka M;Rosell R;Sequist L;Wu Y.L;Marschner I;Lord S;Lee C.K; Lee C.K; Lord S; Marschner I; Wu Y.L; Sequist L; Rosell R; Fukuoka M; Mitsudomi T; Asher R; Davies L; Gebski V; Gralla R; Mok T; Chih-Hsin CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-26T09:26:27Z |
Afatinib as First-line Treatment of Older Patients With EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Subgroup Analyses of the LUX-Lung 3, LUX-Lung 6, and LUX-Lung 7 Trials
|
Park K.;Paz-Ares L; Chih-Hsin Yang;M?rten A;Peil B;Mok T;Boyer M;O'Byrne K;Yamamoto N;Hirsh V;Schuler M;Barrios C.H;Kato T;Tsai C.-M;Lee K.H;Zhang L;Orlov S;Geater S.L;Tan E.-H;Sequist L.V;Wu Y.-L; Wu Y.-L; Sequist L.V; Tan E.-H; Geater S.L; Orlov S; Zhang L; Lee K.H; Tsai C.-M; Kato T; Barrios C.H; Schuler M; Hirsh V; Yamamoto N; O'Byrne K; Boyer M; Mok T; Peil B; Märten A; Chih-Hsin CHIH-HSIN YANG; Paz-Ares L; Park K. |
| 臺大學術典藏 |
2020-05-26T09:26:25Z |
Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib after Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients with EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer
|
Tan D.S.W.;Akimov M;Peng B;Zhao S;Pultar P;Glaser S;Chia V;Felip E;Su W.-C;Vansteenkiste J.F;Ahn M.-J;Chih-Hsin Yang;Lee D.H;Liu X;Kim D.-W;Zhang L;Wu Y.-L; Wu Y.-L; Zhang L; Kim D.-W; Liu X; Lee D.H; CHIH-HSIN YANG; Ahn M.-J; Vansteenkiste J.F; Su W.-C; Felip E; Chia V; Glaser S; Pultar P; Zhao S; Peng B; Akimov M; Tan D.S.W. |
| 臺大學術典藏 |
2020-05-26T09:26:22Z |
Pan-asian adapted clinical practice guidelines for the management of patients with metastatic non-small-cell lung cancer: A csco-esmo initiative endorsed by jsmo, ksmo, mos, sso and tos
|
Chang J.W.C; Alip A; Peters S; Douillard J.-Y.; Soo R.A; Park K; Mitsudomi T; Azrif M; CHIH-HSIN YANG; Tan D.S.W; Kim D.-W; Wu Y.-L;Planchard D;Lu S;Sun H;Yamamoto N;Kim D.-W;Tan D.S.W;Chih-Hsin Yang;Azrif M;Mitsudomi T;Park K;Soo R.A;Chang J.W.C;Alip A;Peters S;Douillard J.-Y.; Wu Y.-L; Planchard D; Lu S; Sun H; Yamamoto N |
| 臺大學術典藏 |
2020-05-26T09:26:21Z |
Sequencing of therapy following first-line afatinib in patients with EGFR mutation-positive non-small cell lung cancer
|
Park K;Bennouna J;Boyer M;Hida T;Hirsh V;Kato T;Lu S;Mok T;Nakagawa K;O'Byrne K;Paz-Ares L;Schuler M;Sibilot D.M;Tan E.-H;Tanaka H;Wu Y.-L;Chih-Hsin Yang;Zhang L;Zhou C;M?rten A;Tang W;Yamamoto N.; Park K; Bennouna J; Boyer M; Hida T; Hirsh V; Kato T; Lu S; Mok T; Nakagawa K; O'Byrne K; Paz-Ares L; Schuler M; Sibilot D.M; Tan E.-H; Tanaka H; Wu Y.-L; CHIH-HSIN YANG; Zhang L; Zhou C; Märten A; Tang W; Yamamoto N. |
| 臺大學術典藏 |
2020-05-26T09:26:20Z |
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trials
|
Schuler M;Paz-Ares L;Sequist L.V;Hirsh V;Lee K.H;Wu Y.-L;Lu S;Zhou C;Feng J;Ellis S.H;Samuelsen C.H;Tang W;M?rten A;Ehrnrooth E;Park K;Chih-Hsin Yang; Schuler M; Paz-Ares L; Sequist L.V; Hirsh V; Lee K.H; Wu Y.-L; Lu S; Zhou C; Feng J; Ellis S.H; Samuelsen C.H; Tang W; Märten A; Ehrnrooth E; Park K; CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-05-25T02:45:31Z |
An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non�Vsmall cell lung cancer
|
Wang L; Wu Y.-L; Lu S; Deng L; Ahn M.-J; Feng-Ming Hsu; Iscoe N; Hossain A; Puri T; Zhang P; Orlando M. |
| 臺大學術典藏 |
2020-05-12T02:53:36Z |
Fabrication of 2D ordered structure of self-assembled block copolymers containing gold nanoparticles
|
Dai, C.-A.; Wu, Y.-L.; Lee, Y.-H.; Chang, C.-J.; Su, W.-F.; WEI-FANG SU |
| 臺大學術典藏 |
2020-03-31T03:59:37Z |
N-α-Acetyltransferase 10 Protein Suppresses Cancer Cell Metastasis by Binding PIX Proteins and Inhibiting Cdc42/Rac1 Activity
|
Wu Y.-L.; Chi C.-C.; Kao H.-J.; Shih H.-J.; Chen M.-W.; Chien M.-H.; Chen P.-S.; Lee W.-J.; Cheng T.-Y.; Rosenberger G.; Chai C.-Y.; Yang C.-J.; Huang M.-S.; Lai T.-C.; Chou T.-Y.; Hsiao M.; Kuo M.-L.; Hua K.-T. ;Tan C.-T. ;Johansson G. ;Jang-Ming Lee ;Yang P.-W. ;Lu H.-Y. ;Chen C.-K. ;Su J.-L. ;Chen P.B. ;Wu Y.-L. ;Chi C.-C. ;Kao H.-J. ;Shih H.-J. ;Chen M.-W. ;Chien M.-H. ;Chen P.-S. ;Lee W.-J. ;Cheng T.-Y. ;Rosenberger G. ;Chai C.-Y. ;Yang C.-J. ;Huang M.-S. ;Lai T.-C. ;Chou T.-Y. ;Hsiao M. ;Kuo M.-L.; Chen P.B.; Su J.-L.; Chen C.-K.; Lu H.-Y.; Yang P.-W.; Johansson G.; JANG-MING LEE; Tan C.-T.; Hua K.-T. |
| 臺大學術典藏 |
2020-03-25T02:36:40Z |
Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection
|
Lee C.-C.; SHYR-CHYR CHEN; Tsai C.-H.; Ma M.H.-M.; Hsu W.-T.; Lee C.-C.;SHYR-CHYR CHEN;Tsai C.-H.;Ma M.H.-M.;Hsu W.-T.;Wu Y.-L.;Hsein Y.-C.;Yo C.-H.; Yo C.-H.; Hsein Y.-C.; Wu Y.-L. |
| 臺大學術典藏 |
2020-03-24T03:47:56Z |
Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection
|
Tsai C.-H.; Chen S.-C.; CHIEN-CHANG LEE; Ma M.H.-M.; Wu Y.-L.; Hsu W.-T.; Hsein Y.-C.; Yo C.-H.; CHIEN-CHANG LEE;Chen S.-C.;Tsai C.-H.;Ma M.H.-M.;Hsu W.-T.;Wu Y.-L.;Hsein Y.-C.;Yo C.-H. |
| 臺大學術典藏 |
2020-03-23T05:54:13Z |
CTGF enhances the motility of breast cancer cells via an integrin-αvβ3-ERK1/2-dependent S100A4-upregulated pathway
|
Chen P.-S.;Wang M.-Y.;Wu S.-N.;Su J.-L.;Hong C.-C.;Chuang S.-E.;Chen M.-W.;Hua K.-T.;Wu Y.-L.;Cha S.-T.;Babu M.S.;Chiung-Nien Chen;Lee P.-H.;Chang K.-J.;Kuo M.-L.; Chen P.-S.; Wang M.-Y.; Wu S.-N.; Su J.-L.; Hong C.-C.; Chuang S.-E.; Chen M.-W.; Hua K.-T.; Wu Y.-L.; Cha S.-T.; Babu M.S.; CHIUNG-NIEN CHEN; Lee P.-H.; Chang K.-J.; Kuo M.-L. |
| 臺大學術典藏 |
2020-03-12T01:40:02Z |
Subaortic blind mitral pouch in a double-inlet right ventricle
|
Wu Y.L.;Chen M.R.;Ing-Sh Chiu;Chen B.F.; Wu Y.L.; Chen M.R.; ING-SH CHIU; Chen B.F. |
| 臺大學術典藏 |
2020-03-09T07:31:24Z |
Unusual complication of central venous catheterization
|
NAI-KUAN CHOU; Wu Y.-L. |
| 臺大學術典藏 |
2020-03-09T04:24:05Z |
Modulation of keratin in adhesion, proliferation, adipogenic, and osteogenic differentiation of porcine adipose-derived stem cells
|
Wu Y.-L.;Lin C.-W.;Nai-Chen Cheng;Yang K.-C.;Yu J.; Wu Y.-L.; Lin C.-W.; NAI-CHEN CHENG; Yang K.-C.; Yu J. |
| 臺大學術典藏 |
2020-03-04T05:42:43Z |
Atrial fibrillation trial to evaluate real-world procedures for their utility in helping to lower stroke events (AFTER-PULSE): Study protocol for a randomized controlled trial
|
Hsieh T.-T; Lee M; Huang W.-Y; SUNG-CHUN TANG; Sung S.-F; Chang K.-H; Lee J.-D; Lee T.-H; Huang Y.-S; Jeng J.-S; Chung C.-M; Wu Y.-L; Ovbiagele B. |
| 臺大學術典藏 |
2020-03-04T05:42:42Z |
Utilization of statins beyond the initial period after stroke and 1-year risk of recurrent stroke
|
Lee M; Saver J.L; Wu Y.-L; SUNG-CHUN TANG; Lee J.-D; Rao N.M; Wang H.-H; Jeng J.-S; Lee T.-H; Chen P.-C; Ovbiagele B. |
| 臺大學術典藏 |
2020-03-03T03:06:45Z |
Acupuncture effects on cardiac functions measured by cardiac magnetic resonance imaging in a feline model
|
Lin J.-H.;Shih C.-H.;Kaphle K.;Wu L.-S.;Wen-Yih Tseng;Chiu J.-H.;Lee T.-C.;Wu Y.-L.; Lin J.-H.; Shih C.-H.; Kaphle K.; Wu L.-S.; WEN-YIH TSENG; Chiu J.-H.; Lee T.-C.; Wu Y.-L. |
| 臺大學術典藏 |
2020-03-02T12:10:54Z |
Atrial fibrillation trial to evaluate real-world procedures for their utility in helping to lower stroke events (AFTER-PULSE): Study protocol for a randomized controlled trial
|
Hsieh T.-T; Lee M; Huang W.-Y; SUNG-CHUN TANG; Sung S.-F; Chang K.-H; Lee J.-D; Lee T.-H; Huang Y.-S; Jeng J.-S; Chung C.-M; Wu Y.-L; Ovbiagele B. |
| 臺大學術典藏 |
2020-03-02T12:10:53Z |
Utilization of statins beyond the initial period after stroke and 1-year risk of recurrent stroke
|
Lee M; Saver J.L; Wu Y.-L; SUNG-CHUN TANG; Lee J.-D; Rao N.M; Wang H.-H; Jeng J.-S; Lee T.-H; Chen P.-C; Ovbiagele B. |
